Flügel, Alexander
29
Apr
/

Flügel, Alexander

Alexander Flügel

Institute for Neuroimmunology and Multiple Sclerosis

University Medical Center Göttingen

Georg-August University Göttingen
Göttingen | Germany


Professor Alexander Flügel took up his current position at the Georg-August University Göttingen as Director of the Institute for Multiple Sclerosis Research and Neuroimmunology in 2008. His main research interest is the mechanisms and factors that allow immune cells to enter the central nervous system, to communicate in this milieu and to influence brain tissue, particularly in relation to multiple sclerosis. He is an expert in applying and optimizing intravital imaging technologies such as two-photon laser scanning microscopy to analyze the autoimmune attack for the CNS in models of experimental autoimmune encephalitis (EAE), an animal model for multiple sclerosis.

29
Apr
/

Heneka, Michael

Michael Heneka

Department of Neurodegenerative Diseases & Gerontopsychiatry/Neurology
University Hospital Bonn
Bonn | Germany


The role of astro- and microglia for neurodegenerative disease has been underestimated.

29
Apr
/

Kerschensteiner, Martin

Martin Kerschensteiner

University of Munich
Munich | Germany


Martin Kerschensteiner is the Chair for Neurosciences and Clinical Neuroimmunology and the Director of the Institute of Clinical Neuroimmunology at the Ludwig-Maximilians University in Munich.
He received his medical training at the RWTH Aachen and Ludwig-Maximilians Universitiy (LMU) in Munich and performed his MD thesis at the Max-Planck Institute of Neurobiology.  He received clinical training at the Department of Neurology of the LMU Munich and postdoctoral training at the Brain Research Institute of ETH Zurich, at Washington University in St. Louis and at Harvard University. After returning to Germany as a junior group leader, he was promoted to Associate Professor in 2008 and to Full Professor and Chair of the Institute of Clinical Neuroimmunology at LMU Munich in 2013.
Professor Kerschensteiner`s research focuses on understanding the mechanisms of tissue damage and repair in neuroinflammatory conditions and the development of neuroprotective and regenerative treatment strategies. He is the deputy director of the Biomedical Center of the LMU Munich as well as member of the executive boards of the Collaborative Research Center on Multiple Sclerosis (SFB/Tr128), the German Competence Network Multiple Sclerosis (KKNMS) and the Munich Excellence Cluster for Systems Neurology (SyNergy).

29
Apr
/

Korn, Thomas

Thomas Korn, MD

Technical University of Munich
Department of Neurology and Neuroimmunology
Munich | Germany


In our work, we would like to understand how specific properties are imprinted in autoreactive T cells in the peripheral immune compartment that later dictate their effector functions in the central nervous system.

29
Apr
/

Mantovani, Alberto

Alberto Mantovani

Humanitas University
Milan | Italy


Alberto Mantovani, MD, is Emeritus Professor of Pathology at the Humanitas University in Milan, and Scientific Director of the Istituto Clinico Humanitas. His attention has been focused on the molecular mechanisms of innate immunity and inflammation. He has contributed to the advancement of knowledge in the field of Immunology formulating new paradigms and identifying new molecules and functions.

For his research activity he has received several national and international awards, such as the Triennial OECI Award from the Organization of the European Cancer Institutes, the Robert Koch Award for his contribution to tumor immunology and immunotherapy, the American-Italian Cancer Foundation (AICF) Prize for Excellence in Medicine and, most recent, the American Association for Cancer Research International Pezcoller Award for Extraordinary Achievement in Cancer Research. The broad impact of his contributions is testified by citations. As of November 2019 he has over 115,900 (Scopus), 108,900 (Web of Science) or 166,900 (Google Scholar) citations and an H-index of 163 (Scopus), 161 (Web of Science) or 187 (Google Scholar).

29
Apr
/

Rescigno, Maria

Maria Rescigno

Humanitas University
Milan | Italy


Mucosal Immunology, host-microbe interactions in the gut-liver-brain axis.

29
Apr
/

Sankowski, Roman

Roman Sankowski

Institute of Neuropathology
Department of Neurology and Neurosciences
University Medical Center
Freiburg | Germany


Roman Sankowski has studied Medicine at Marburg University and did a PhD at the Feinstein Institute in New York, United States. He is currently doing residency at the Institute for Neuropathology at the University of Freiburg Medical Center. His research topic are myeloid cells of the brain in the health disease.

29
Apr
/

Schirmer, Lucas

Lucas Schirmer

University of Heidelberg
Heidelberg | Germany


Dr. Schirmer is a physician-scientist focusing on neurobiological mechanisms in progressive neuroinflammation, such as multiple sclerosis. Work in his lab combines a broad spectrum of methods like single-cell genomics, experimental models and human pathology in a synergistic way. His lab has a major interest in studying cell-type specific disease mechanisms with an emphasis on neuron subtype pathology and reactive immune and glial cell types.

29
Apr
/

Smith, Ken

Ken Smith

Cambridge University
Cambridge | UK


Ken Smith is Professor of Medicine and Head of the Department of Medicine at the University of Cambridge.. Ken trained in nephrology and clinical immunology in Melbourne, and completed his PhD at the Walter and Eliza Hall Institute. He is a Wellcome Trust Investigator, leads an MRC Programme, was elected a Fellow of the Academy of Medical Sciences in 2006, and was awarded the Lister Institute Research Prize in 2007. His laboratory studies immunological mechanisms underlying immune-mediated disease and immunodeficiency in humans, most recently through involvement in the NIHR BioResource Rare Diseases Primary immunodeficiency programme. The lab also runs a translational program in autoimmune disease (particularly SLE, vasculitis and IBD) that has led to the discovery of a prognosis-predicting biomarker entering clinical trials, and to the identification of new pathways driving disease outcomes in autoimmunity and infection. By integrating human and animal studies and using advanced bioinformatic methodology, the laboratory tries to explore fundamental immunological mechanisms that are relevant to human disease, and to translate these results into applications of direct benefit to patients.

29
Apr
/

Yong, V. Wee

V. Wee Yong

Hotchkiss Brain Institute and
Departments of Clinical Neurosciences and Oncology
Calgary | Canada


Dr. Wee Yong is a Professor at the University of Calgary, Canada. He co-leads the Multiple Sclerosis (MS) NeuroTeam at the university and he directs the provincial Alberta MS Network. Dr. Yong’s research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects are guided by MS and brain tumors.  Dr. Yong has published 310 peer-reviewed manuscripts and his research has been translated into Phase III clinical trials in MS and spinal cord injury; he has received national funding for a Phase I/IIa trial in glioblastoma.  His work has been cited over 21,000 times (web of science; h-index of 81). Dr. Yong is a past chair of the Medical Advisory Committee of the MS Society of Canada. He has been the President of the International Society of Neuroimmunology (2014-2016) and he continues to co-direct its Global Schools of Neuroimmunology (with Dr. Gianvito Martino). Dr. Yong is an elected fellow of both the Canadian Academy of Health Sciences and the Royal Society of Canada. He is the 2017 Allyn Taylor International Prize in Medicine winner.